G01N2333/605 - CPC Classification Index

#1

20250346646

2025-11-13

COMPOUNDS USEFUL TO TREAT METABOLIC DISORDERS

#2

20250283891

2025-09-11

METHODS FOR DETECTING METABOLIC MARKERS

#3

20240376192

2024-11-14

METHODS AND SYSTEMS FOR DETECTING PEPTIDE AGGREGATES

#4

20240307466

2024-09-19

Methods and Compositions Relating to Microbial Treatment and Diagnosis of Disorders

#5

20240159776

2024-05-16

Precision Medicine Approach to Targeting Neurodegeneration

#6

20220065874

2022-03-03

METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES

#7

20210386798

2021-12-16

Methods and compositions relating to microbial treatment and diagnosis of disorders

#8

20210171599

2021-06-10

COMPOUNDS USEFUL TO TREAT METABOLIC DISORDERS

#9

20210069123

2021-03-11

Method for screening for diabetes mellitus therapeutic agents

#10

20200345796

2020-11-05

Methods and compositions relating to microbial treatment and diagnosis of disorders

#11

20200308273

2020-10-01

Methods and systems for detecting peptide aggregates

#12

20200261518

2020-08-20

Methods and compositions relating to microbial treatment and diagnosis of disorders

#13

20200261517

2020-08-20

Methods and compositions relating to microbial treatment and diagnosis of disorders

#14

20190219597

2019-07-18

IN VITRO METHOD FOR DIAGNOSING AT EARLY STAGE INTESTINAL ISCHEMIA

#15

20190135888

2019-05-09

COMPOUNDS USEFUL TO TREAT METABOLIC DISORDERS

#16

20190127433

2019-05-02

Glucagon/GLP-1 receptor co-agonists

#17

20190125829

2019-05-02

METHOD FOR PREVENTING OBESITY-INDUCED FATTY LIVER BY INHIBITING KCTD17

#18

20190070228

2019-03-07

Methods and compositions relating to microbial treatment and diagnosis of disorders

#19

20190070227

2019-03-07

METHODS AND COMPOSITIONS RELATING TO MICROBIAL TREATMENT AND DIAGNOSIS OF DISORDERS

#20

20190030096

2019-01-31

Methods and compositions relating to microbial treatment and diagnosis of disorders

#21

20190030095

2019-01-31

Methods and compositions relating to microbial treatment and diagnosis of disorders

#22

20180038875

2018-02-08

METHODS FOR THE IDENTIFICATION, ASSESSMENT, PREVENTION, AND TREATMENT OF NEUROLOGICAL DISORDERS AND DISEASES

#23

20170369569

2017-12-28

Anti-active GIP antibody

#24

20170349642

2017-12-07

Glucagon/GLP-1 receptor co-agonists

#25

20170027996

2017-02-02

Methods and compositions relating to microbial treatment and diagnosis of disorders

#26

20160228476

2016-08-11

Methods and compositions relating to microbial treatment and diagnosis of disorders

#27

20160175263

2016-06-23

Method for preventing or treating diabetes mellitus, and method for screening for diabetes mellitus therapeutic agent

#28

20150376256

2015-12-31

Glucagon/GLP-1 receptor co-agonists

#29

20150153329

2015-06-04

ASSAY SYSTEM FOR GLP-2 RECEPTOR LIGANDS

#30

20140206607

2014-07-24

Glucagon/GLP-1 receptor co-agonists

#31

20140199711

2014-07-17

Method for determining glucagon-like peptide-1, and kit for use in said method

#32

20140179899

2014-06-26

Double-acylated GLP-1 derivatives

#33

20140024065

2014-01-23

Ex vivo method for determining potential GLP-2 receptor modulators

#34

20130284912

2013-10-31

Quantification of impurities for release testing of peptide products

#35

20130053311

2013-02-28

GLP-1 analogues and derivatives

#36

20130005050

2013-01-03

Glucagon detection and quantitation by mass spectrometry

#37

20120329711

2012-12-27

GLP-1 RECEPTOR AGONIST COMPOUNDS WITH A MODIFIED N-TERMINUS

#38

20120329708

2012-12-27

Glucagon/GLP-1 receptor co-agonists

#39

20120329707

2012-12-27

Glucagon/GLP-1 receptor co-agonists

#40

20120295298

2012-11-22

Ex vivo method for determining potential GLP-2 receptor modulators

#41

20120003681

2012-01-05

Ex vivo method for determining potential GLP-2 receptor modulators

#42

20110294735

2011-12-01

MECHANISM OF NEUROMEDIN U ACTION AND USES THEREOF

#43

20110166321

2011-07-07

Double-acylated GLP-1 derivatives

#44

20110028335

2011-02-03

Ligands for the GLP-1 receptor and methods for discovery thereof

#45

20100297253

2010-11-25

Treatment of diabetes with milk protein hydrolysate

#46

20100003703

2010-01-07

Ex vivo method for determining potential GLP-2 receptor modulators

#47

20090181887

2009-07-16

USE OF A GLP-1 MOLECULE FOR TREATMENT OF BILIARY DYSKINESIA AND/OR BILIARY PAIN/DISCOMFORT

#48

20090123951

2009-05-14

Method Of Diagnosing A Body Weight Condition Or Predisposition

#49

20070154959

2007-07-05

Assay system for GLP-2 receptor ligands

#50

20070128193

2007-06-07

GLP-1 agonists, compositions, methods and uses

#51

20060223767

2006-10-05

Vector for gene therapy and method of quantifying target protein in mammal or cultured cells with the administration of the vector for gene therapy

#52

20050186558

2005-08-25

Treatment of diabetes with milk protein hydrolysate